Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCCH type-containing protein 12C (ZC3H12C) is a member of the CCCH-type zinc finger protein family, functioning as an RNA-binding protein with probable ribonuclease (RNase) activity. It participates in post-transcriptional regulation of gene expression by degrading specific mRNA targets, thereby modulating cellular processes such as macrophage activation and the innate immune response. ZC3H12C negatively regulates proinflammatory activation in macrophages, likely contributing to the control of inflammation during the immune response. Its activity is important for immune homeostasis, with emerging evidence implicating it in inflammation-related disease pathways.
RNA endonuclease activity (degradation of specific mRNAs); Modulation of inflammatory gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCCH type-containing protein 12C (ZC3H12C).